Images of three receptor tyrosine kinases (IMAGE) Society of Nuclear Medicine and Molecular Imaging Caption Three receptor tyrosine kinases (RTKs)--EGFR (orange), HER2 (pink), and MET (green)--are imaged before and after the use of a MET-selective tyrosine kinase inhibitor (Trametinib), and trametinib, a mitogen activated protein kinase (MEK) inhibitor, showing its potential effectiveness for treating a tumor. Credit Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center Usage Restrictions Please give appropriate credit. License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.